Methyl 4-Oxocyclohexanecarboxylate is an intermediate for preparation of imidazobenzazepine derivatives as dual H1/5-HT2A antagonists for treatment of sleep disorders.
Monti, J., et al.: CNS Drugs, 13, 87 (2000), Tashiro, M., et al.: Life Sci., 72, 409 (2002), Popa, D., et al.: J. Neurosci., 25, 11231 (2005),
400-821-0725
沪ICP备17019645号
